FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023941817> ?p ?o ?g. }

• W2023941817 endingPage "414" @default.
• W2023941817 startingPage "406" @default.
• W2023941817 abstract "Background: The interplay between numerous factors, including the size, shape, coating, surface charge and composition of particles is known to affect the pharmacokinetics and biodistribution of superparamagnetic iron oxides (SPIOs). This makes understanding the role of each factor independently quite challenging.Methods: In the present study, the in vivo magnetic resonance imaging (MRI), biodistribution and hepatic clearance evaluations of two SPIOs Formulations A and B developed from ∼13.5 nm hydrophobic oleic acid stabilized monodisperse magnetite nanocrystals core and lipid-based amphiphilic stabilizers were performed using a prototype benchtop MR imager (22 MHz) and pulsed nuclear magnetic resonance (NMR) system (20 MHz), respectively. Formulation A was composed of mPEG-2000-DSPE and Formulation B was composed of Phospholipon-100H, sucrose ester M-1695 and Cremophor RH-40.Results: The in vivo MRI investigations showed that both formulations were safe and effective as potential liver MR contrast agents with sustained liver contrast for at least seven days. In addition, ex vivo relaxometric investigations revealed that the formulations predominantly distribute to the liver and spleen following I.V. injection. The hepatic clearance kinetics determined based on the relaxometric quantification method indicated that both formulations exhibited a biphasic clearance process with a slow terminal clearance half-life of 11.5 and 12.7 days, respectively, for Formulations A and B.Conclusions: The results of this study showed the potential biomedical applications of the investigated magnetopharmaceutical formulations as MRI contrast agents." @default.
• W2023941817 created "2016-06-24" @default.
• W2023941817 creator A5042560200 @default.
• W2023941817 creator A5062932587 @default.
• W2023941817 creator A5065851642 @default.
• W2023941817 creator A5089889921 @default.
• W2023941817 date "2013-12-20" @default.
• W2023941817 modified "2023-10-16" @default.
• W2023941817 title "Benchtop MRI for pharmacokinetic evaluation of two aqueous-based nano-scaled formulations of oleic acid stabilized magnetite nanocrystals" @default.
• W2023941817 cites W1966475330 @default.
• W2023941817 cites W1972380343 @default.
• W2023941817 cites W1973901460 @default.
• W2023941817 cites W1981158098 @default.
• W2023941817 cites W1984232298 @default.
• W2023941817 cites W1987924718 @default.
• W2023941817 cites W2003429108 @default.
• W2023941817 cites W2012259560 @default.
• W2023941817 cites W2015325450 @default.
• W2023941817 cites W2020445899 @default.
• W2023941817 cites W2030003406 @default.
• W2023941817 cites W2030161373 @default.
• W2023941817 cites W2036670812 @default.
• W2023941817 cites W2037458039 @default.
• W2023941817 cites W2037936835 @default.
• W2023941817 cites W2043420817 @default.
• W2023941817 cites W2052115316 @default.
• W2023941817 cites W2055758067 @default.
• W2023941817 cites W2056461814 @default.
• W2023941817 cites W2058863059 @default.
• W2023941817 cites W2063909048 @default.
• W2023941817 cites W2066285843 @default.
• W2023941817 cites W2068858353 @default.
• W2023941817 cites W2071125913 @default.
• W2023941817 cites W2071794337 @default.
• W2023941817 cites W2076338426 @default.
• W2023941817 cites W2084916305 @default.
• W2023941817 cites W2086171977 @default.
• W2023941817 cites W2088525015 @default.
• W2023941817 cites W2094066733 @default.
• W2023941817 cites W2101312385 @default.
• W2023941817 cites W2110118058 @default.
• W2023941817 cites W2118969052 @default.
• W2023941817 cites W2119291163 @default.
• W2023941817 cites W2120746908 @default.
• W2023941817 cites W2144611965 @default.
• W2023941817 cites W2158368253 @default.
• W2023941817 cites W2320636938 @default.
• W2023941817 cites W2502670554 @default.
• W2023941817 cites W3105059679 @default.
• W2023941817 doi "https://doi.org/10.3109/03639045.2013.871552" @default.
• W2023941817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24354323" @default.
• W2023941817 hasPublicationYear "2013" @default.
• W2023941817 type Work @default.
• W2023941817 sameAs 2023941817 @default.
• W2023941817 citedByCount "2" @default.
• W2023941817 countsByYear W20239418172016 @default.
• W2023941817 countsByYear W20239418172022 @default.
• W2023941817 crossrefType "journal-article" @default.
• W2023941817 hasAuthorship W2023941817A5042560200 @default.
• W2023941817 hasAuthorship W2023941817A5062932587 @default.
• W2023941817 hasAuthorship W2023941817A5065851642 @default.
• W2023941817 hasAuthorship W2023941817A5089889921 @default.
• W2023941817 hasConcept C112705442 @default.
• W2023941817 hasConcept C11432220 @default.
• W2023941817 hasConcept C121332964 @default.
• W2023941817 hasConcept C150903083 @default.
• W2023941817 hasConcept C155672457 @default.
• W2023941817 hasConcept C15920480 @default.
• W2023941817 hasConcept C171250308 @default.
• W2023941817 hasConcept C178790620 @default.
• W2023941817 hasConcept C185592680 @default.
• W2023941817 hasConcept C188027245 @default.
• W2023941817 hasConcept C192562407 @default.
• W2023941817 hasConcept C202751555 @default.
• W2023941817 hasConcept C207001950 @default.
• W2023941817 hasConcept C2777807558 @default.
• W2023941817 hasConcept C2778978742 @default.
• W2023941817 hasConcept C2781403372 @default.
• W2023941817 hasConcept C46141821 @default.
• W2023941817 hasConcept C521977710 @default.
• W2023941817 hasConcept C55493867 @default.
• W2023941817 hasConcept C67407626 @default.
• W2023941817 hasConcept C71924100 @default.
• W2023941817 hasConcept C86803240 @default.
• W2023941817 hasConcept C98274493 @default.
• W2023941817 hasConceptScore W2023941817C112705442 @default.
• W2023941817 hasConceptScore W2023941817C11432220 @default.
• W2023941817 hasConceptScore W2023941817C121332964 @default.
• W2023941817 hasConceptScore W2023941817C150903083 @default.
• W2023941817 hasConceptScore W2023941817C155672457 @default.
• W2023941817 hasConceptScore W2023941817C15920480 @default.
• W2023941817 hasConceptScore W2023941817C171250308 @default.
• W2023941817 hasConceptScore W2023941817C178790620 @default.
• W2023941817 hasConceptScore W2023941817C185592680 @default.
• W2023941817 hasConceptScore W2023941817C188027245 @default.
• W2023941817 hasConceptScore W2023941817C192562407 @default.
• W2023941817 hasConceptScore W2023941817C202751555 @default.
• W2023941817 hasConceptScore W2023941817C207001950 @default.

• next